Abstract

Purpose Because of the increased risk of long-term sickness leave for employees with a major depressive disorder (MDD), it is important for occupational health professionals to recognize depression in a timely manner. The Patient Health Questionnaire-9 (PHQ-9) has proven to be a reliable and valid instrument for screening MDD, but has not been validated in the occupational health setting. The aim of this study was to validate the PHQ-9 for MDD within a population of employees on sickness leave by using the MINI-International Neuropsychiatric Interview (MINI) as a gold standard. Methods Participants were recruited in collaboration with the occupational health service. The study sample consisted of 170 employees on sickness leave between 4 and 26 weeks who completed the PHQ-9 and were evaluated with the MINI by telephone. Sensitivity, specificity, positive and negative predictive value, efficiency and 95 % confidence intervals (95 % CIs) were calculated for all possible cut-off values. A receiver operator characteristics (ROC) analysis was computed for PHQ-9 score versus the MINI. Results The optimal cut-off value of the PHQ-9 was 10. This resulted in a sensitivity of 86.1 % [95 % CI (69.7–94.8)] and a specificity of 78.4 % [95 % CI (70.2–84.8)]. Based on the ROC analysis, the area under the curve for the PHQ-9 was 0.90 [SE = 0.02; 95 % CI (0.85–0.94)]. Conclusion The PHQ-9 shows good sensitivity and specificity as a screener for MDD within a population of employees on sickness leave.

Highlights

  • Major depressive disorders (MDD) are highly associated with sickness leave, and lead to personal suffering and high societal costs [1, 2]

  • Purpose Because of the increased risk of longterm sickness leave for employees with a major depressive disorder (MDD), it is important for occupational health professionals to recognize depression in a timely manner

  • The aim of this study was to validate the Patient Health Questionnaire-9 (PHQ-9) for MDD within a population of employees on sickness leave by using the MINI-International Neuropsychiatric Interview (MINI) as a gold standard

Read more

Summary

Introduction

Major depressive disorders (MDD) are highly associated with sickness leave, and lead to personal suffering and high societal costs [1, 2]. Employees with MDD are at risk for long-term sickness leave [4, 5]. Long-term sickness leave is responsible for enormous costs for patients, companies and society as a whole. Because of the increased risk of long-term sickness leave for employees with a MDD, it is important for occupational health professionals (e.g., occupational physicians) to be able to recognize depression and start or refer to treatment in a timely manner. The availability of good screening instruments for depression among employees on sickness leave is important. For the occupational health (OH) setting, these instruments must be brief, easy to use and reliable and valid for the specific population

Objectives
Methods
Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call